Soleus Capital Management, L.P.
Position in TNDM — Tandem Diabetes Care Inc
CIK 1802630
GREENWICH, CT
Position in TNDM
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$15,010,110
+$11,282,110 QoQ
Shares Held
783,000
+291.5% QoQ
Ownership
1.14%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TNDM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Soleus Capital Management, L.P. holds $529,137,690 across 15 Medical Devices names. TNDM ranks #10 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PODD |
Insulet Corp
|
562,500 | $118,035,000 | |
| 2 | NVCR |
NovoCure Ltd
|
10,492,391 | $114,367,061 | |
| 3 | GMED |
Globus Medical Inc
|
729,467 | $62,850,876 | |
| 4 | BBNX |
Beta Bionics, Inc.
|
4,354,501 | $43,632,100 | |
| 5 | NPCE |
NeuroPace Inc
|
2,932,207 | $38,558,522 | |
| 6 | LIVN |
LivaNova PLC
|
582,500 | $37,023,700 | |
| 7 | INSP |
Inspire Medical Systems, Inc.
|
576,299 | $29,725,502 | |
| 8 | AXGN |
Axogen, Inc.
|
679,170 | $22,500,902 |
All Filings in TNDM
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,010,110 | 783,000 | Shares | Sole | 2026-05-14 | |
| 2025-06-30 | $3,728,000 | 200,000 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $9,504,107 | 496,039 | Shares | Sole | 2025-05-15 | |
| 2023-03-31 | $8,256,013 | 203,300 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $14,046,875 | 312,500 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $19,867,320 | 415,200 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $10,879,122 | 183,800 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||